Prednisone for Non-Specific Pleuritis
Part of Infections, Lungs & breathing clinical trials.
This trial tests if a short course of the steroid prednisone can help people with nonspecific pleuritis—inflammation of the lung lining without a known cause. If you haven't responded to other treatments, this study aims to see if prednisone is a safe and effective option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with non-specific pleuritis (inflammation of the lining around your lungs that doesn't have a clear cause). The diagnosis must be confirmed by a biopsy (a small sample taken from the lining).
- Blood tests for autoimmune diseases (like lupus, rheumatoid arthritis, and others) must be negative.
- You cannot have chronic or fibrinous pleuritis (a long-term, scar-like form of the condition).
- You cannot have empyema (a pocket of pus in the chest caused by infection).
- You cannot be taking steroids or other immune-suppressing medicines for any other reason right now.
- You must be able to understand the study and give your own consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether prednisolone (a steroid medicine) helps people with acute interstitial nephritis, a sudden inflammation of the kidney tissue. You may qualify if your diagnosis was confirmed by kidney biopsy and your kidney function has worsened recently.
This trial tests whether taking a corticosteroid (a type of anti-inflammatory medicine) for six months can help people with fibrotic hypersensitivity pneumonitis, a lung disease that causes scarring and makes it hard to breathe. The study compares the drug to a placebo (a pill with no active medicine) to see if it improves lung function or slows down the disease.
This trial tests whether using non-steroidal anti-inflammatory drugs (NSAIDs) during pleurodesis (a procedure to seal the lung lining) helps people with a collapsed lung (pneumothorax). It aims to see if these drugs can improve outcomes.
This trial tests a new approach to treating serious respiratory infections in hospitalized adults. It aims to see if a targeted strategy works better than standard care while avoiding extra risks.
This study tests whether prednisone, a steroid that reduces inflammation, can help people with severe liver injury caused by a medication. It might help if your liver tests are still high even after stopping the medicine that caused the problem.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
Hear when a new Pleuritis, Non-specific trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.